Lannett Concludes It Is In Compliance With Applicable Laws And Regulations

(RTTNews) - Lannett Co. Inc. (LCI) announced that upon receipt of the subpoena from the State of Connecticut Office of the Attorney General it voluntarily engaged outside counsel and other experts to conduct an internal review focusing on the company's pricing practices for digoxin. The review has been completed and the firm concluded that it has acted in compliance with applicable laws and regulations with regard to the pricing of digoxin.

The company received interrogatories and a subpoena in July 2014 from the State of Connecticut Office of the Attorney General concerning its investigation into pricing of digoxin. According to the subpoena, the Connecticut Attorney General is probing whether anyone engaged in any activities that resulted in fixing, maintaining or controlling prices of digoxin or allocating and dividing customers or territories relating to the sale of digoxin in violation of Connecticut antitrust law.